Showing 1 - 3 results of 3 for search 'Juan José Gil Fernández', query time: 0.03s Refine Results
  1. 1
    Isatuximab‐carfilzomib‐dexamethasone immediately after failing of the quadruplet Daratumumab‐bortezomib‐lenalidomide‐dexamethasone (Dara‐VRD): Striking response with no washout in a newly diagnosed multiple myeloma

    Isatuximab‐carfilzomib‐dexamethasone immediately after failing of the quadruplet Daratumumab‐bortezomib‐lenalidomide‐dexamethasone (Dara‐VRD): Striking response with no washout in... by Juan José Gil‐Fernández, Patricia García Ramírez, Marta Callejas Charavía

    Published 2024-01-01
    Get full text
    Article
  2. 2
    Jumping Translocation in a Patient with Acute Leukemia and Fatal Evolution

    Jumping Translocation in a Patient with Acute Leukemia and Fatal Evolution by Irene Sánchez Prieto, Montserrat López Rubio, Eva Arranz, Rosa Ayala, Marta Callejas Charavía, Yolanda Martín Guerrero, Juan José Gil Fernández, Susana Valenciano Martínez, Lucía Castilla García, María Argüello Marina, José María Aspa Cilleruelo, Celia Martínez Vázquez, Julio García Suárez

    Published 2020-09-01
    Get full text
    Article
  3. 3
    PB2618: USE AND DISCONTINUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A SINGLE CENTRE EXPERIENCE

    PB2618: USE AND DISCONTINUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A SINGLE CENTRE EXPERIENCE by Celia Martinez, Paola Villafuerte Gutiérrez, Motornaya Galina, Maria Barbaño Acevedo Gómez, Juan Jose Gil Fernández, Jose Maria Aspa Cilleruelo, Lucia Castilla Garcia, Maria Argüello Marina, Guzman López de Hontanar, Pedro Antonio Rodríguez Barquero, Gili Herreros Paula, Callejas Charavia Marta, Gutierrez Jomarrón Isabel, Magro Mazo Elena, San Andrés Corral Cristina, Julio García Suarez

    Published 2023-08-01
    Get full text
    Article

Search Tools: